Revealed proof derived from clinical trials evaluating the efficacy and security of CBD in clients with gastrointestinal Problems remains scarce. That fact led Dr. Camilleri and Mayo Clinic colleagues to perform a randomized managed demo investigating the use of CBD in people with gastroparesis.